Bliss GVS Pharma has informed that a Meeting of the Board of Directors of the Company will be held on May 28, 2013, to consider the Audited Financial Results of the Company for the year ended March 31, 2013 and dividend.
The above information is a part of company’s filings submitted to BSE.